An intermediate-effect size variant in <i>UMOD</i> confers risk for chronic kidney diseaseEric Olinger, F. Maleady-Crowe, Yurong Cheng et al.|Proceedings of the National Academy of Sciences|2022Cited by 46
An intermediate effect size variant in <i>UMOD</i> confers risk for chronic kidney diseaseEric Olinger, Olivier Devuyst, Céline Schaeffer et al.|medRxiv|2021Cited by 2